Please enable JavaScript
Powered by Benchmark Matribhumi Samachar English - Page 74 of 2798 -
Friday, January 30 2026 | 07:22:03 AM

Graphano Energy Ltd. Completes Airborne Geophysical Survey at Black Pearl

Vancouver, British Columbia–(Newsfile Corp. – January 16, 2026) – Graphano Energy Ltd. (TSXV: GEL) (FSE: 97G0) (OTC Pink: GELEF) (“Graphano” or the “Company“) is pleased to announce the successful completion of its airborne geophysics program totaling 473 kilometres over the Black Pearl property in Québec. Preliminary interpretation confirms a dominant TDEM conductor extending …

Read More »

LDIC Inc. Announces Senior Executive Appointments to Drive the Firm’s Next Chapter of Strategic Growth

Toronto, Ontario–(Newsfile Corp. – January 15, 2026) – LDIC Inc. (“LDIC”) today announced a series of senior executive appointments that position the Firm for continued growth, enhanced client service, and long-term performance excellence. These appointments come as LDIC marks its 27th anniversary since its founding in 1998 and celebrates a …

Read More »

HTX Opens Trading for LIT (Lighter)

Panama City, Panama–(Newsfile Corp. – January 15, 2026) – HTX, a leading global cryptocurrency exchange, has announced the listing of LIT (Lighter) on January 15. LIT/USDT spot trading is now available to users on HTX. LIT, which has a max supply of 1 billion tokens, is the native token of …

Read More »

Mongoose Mining Announces Executive Leadership Realignment

Halifax, Nova Scotia–(Newsfile Corp. – January 15, 2026) – Mongoose Mining Ltd. (CSE: MNG) (“Mongoose” or the “Company”) announces that its Board of Directors has approved a realignment of the Company’s executive leadership structure to support effective governance, operational execution, and external engagement as the Company advances its exploration activities within the …

Read More »

Global Development Accelerates: Leads Biolabs’ PD-L1/4-1BB Bispecific Antibody Granted Fast Track Designation by FDA

Nanjing, China–(Newsfile Corp. – January 15, 2026) – Nanjing Leads Biolabs Co., Ltd. (HKE: 9887) (“Leads Biolabs” or the “Company”) today announced that Opamtistomig (LBL-024), its core investigational PD-L1/4-1BB bispecific antibody, has been granted Fast Track Designation (FTD) by the U.S. Food and Drug Administration (FDA) for the treatment of …

Read More »